Charged Alpha
CHARGED ALPHA · RESEARCH PACKET
Companion to the Q1 FY2027 earnings episode · published October 1, 2026

NKE: The Reset Has a Cash Bill

NIKE, Inc. · NYSE: NKEQuarter ended August 31, 2026Results October 1, 2026 (after U.S. market close; exact release clock unconfirmed)Footwear and apparelPresented by Hudson & Lana
SELLConviction 3 / 5Uncertainty: High
Fair value (base)$25.00range $16.00–$40.00
Price, October 1 saved early post-release reference$32.78-24% to base
Probability-weighted$25.30-23% expected

A stronger margin does not fund the whole reset. Direct sales and Greater China remain weak, while dividends and Pace require cash before the full savings arrive. Our three routes support a rounded $25 central value. At $32.78, the shares price in more recovery than our cash assumptions justify. High uncertainty requires a wider entry cushion.

Layer 1 · fast

The 60-second read

Q1 revenue$11.213B−4% reported /−5% currency-neutral
Gross margin42.8%+60 basis points
NIKE Direct−8%Digital −13%; stores −5%
Greater China−22%Reported; currency-neutral −26%
FY27 adjusted EPS$1.15–$1.35Excludes ~$0.15 Pace cost
Net financial cash$475MCash + investments − debt
Pace savings$2.5BCumulative through FY31; before costs
Central value$25SELL 3/5; high uncertainty

Five things to know

  1. The margin recovery is incomplete. Gross margin rose to 42.8%, but lower sales left operating profit below the prior-year quarter.
  2. Direct demand remains weak. NIKE Direct sales fell 8%, while Greater China revenue fell 22% on a reported basis.
  3. Pace has an upfront cash bill. The $2.5 billion savings estimate is cumulative through FY2031, before $1.0 billion of additional charges and reinvestment.
  4. The dividend needs a funding bridge. FY2026 free cash flow of $2.184 billion was below $2.407 billion of dividends.
  5. Valuation still assumes recovery. Our $25 central value is below the saved $32.78 post-release reference; a $20 entry review requires the thesis to remain intact.
Layer 1 · the call

Three scenarios, one probability-weighted number

Analyst scenarios, not company guidance; USD per share

Scenario values · Analyst values and probabilities.
Bear30%Bear30%: $16.00$16.00Base50%Base50%: $25.00$25.00Bull20%Bull20%: $40.00$40.00WeightedWeighted: $25.30$25.30ReferenceReference: $32.78$32.78
Bear30%Bear30%: $16.00$16.00Base50%Base50%: $25.00$25.00Bull20%Bull20%: $40.00$40.00WeightedWeighted: $25.30$25.30ReferenceReference: $32.78$32.78
Show the data
MeasureValue
Bear30%16.00
Base50%25.00
Bull20%40.00
Weighted25.30
Reference32.78
ScenarioProbability12-month valuevs $32.78What has to happenThe arithmetic
Bear30%$16.00−51%Demand and cash recovery remain weakAbout$0.90EPS×18,rounded$16
Base50%$25.00−24%Moderate operating repair with cash constraintsJudgment within$20.03cash,$24.50enterprise,$27.50earningsroutes
Bull20%$40.00+22%Direct / China recovery and savings convertAnalyst$2sustainableEPS×20

Computed expected value:30%×$16+50%×$25+20%×$40=$25.30. Scenario endpoints are neither floors nor ceilings.

Layer 1 · falsifiable

Signposts: what would change our mind

SignpostNow (Q1 FY2027)Green ifRed ifNext check
Direct sales−8% reportedBetter than −5%Below −10%Q2 ending Nov 30, 2026
Greater China−22% reportedBetter than −15%Below −25%Q2 ending Nov 30, 2026
Gross margin42.8%At / above 43% with healthy salesBelow 42%Q2 ending Nov 30, 2026
FY27 adjusted EPS$1.15–$1.35Midpoint at / above $1.35Low end below $1.15Next FY27 guide update
Cash coverageFY26 FCF / dividends 0.91×Above 1×Below 0.8×FY27 ending May 31, 2027
Pace FY27 chargesAbout $300M expectedWithin plan with measurable savingsHigher cost without better benefitsFY27 ending May 31, 2027
Valuation$32.78referenceNear $20 if thesis intactFundamentals invalidate base caseEach filing after Oct 1, 2026

Analyst decision thresholds established October 1,2026. Future release dates are not assumed; compare consistent definitions.

The Price Still Requires a Recovery

NIKE is getting cheaper because the recovery keeps demanding more time and cash. The useful question is whether the next stage of the reset can produce enough earnings to justify the price investors still pay. Our answer is cautious: SELL, conviction 3 out of 5, with high uncertainty and a rounded $25 central value. This is a valuation judgment about the ordinary shares, not a prediction that the brand stops mattering. The bull case remains credible, but the saved $32.78 post-release reference already charges investors for meaningful improvement.

The source-bound market snapshot separates the $35.15 completed-session quote from the $32.78 extended-hours observation used in this packet. Their ratio gives a decline of about 6.7% since the print. The daily chart uses completed daily closes; it does not pretend that the later observation was a regular-session closing price. Both observations are dated October 1, 2026. Subsequent trading can change the entry decision, and every valuation multiple here should be recomputed against a later price before relying on it.

The stock has fallen a long way from its saved 52-week high, but a discount to a past quotation is not the same as a discount to future cash. Fiscal 2027 adjusted EPS guidance puts the current reference at more than twenty-six times the midpoint. That multiple can work if the brand reaccelerates, margins improve and restructuring benefits reach shareholders. It becomes harder to defend if direct sales keep contracting and the new operating model first consumes the cash that investors expected to receive.

The provider market capitalization accompanies the regular-session quote. For our enterprise-value calculation we instead multiply the same $32.78 valuation reference by the latest diluted weighted-average share proxy, then subtract net financial cash. That produces an internally consistent illustration, while acknowledging that weighted-average shares are not an exact point-in-time share register. The appendix retains the source observations and the distinction. We do not combine a later share price with an earlier capitalization and describe the resulting ratio as precise.

Daily closes and our valuation reference · Completed closes; October 1 $32.78 early post-release reference is separate.
$0.00$20.00$40.00$60.00$80.00$100.00Central value $25Entry review $20Jul 25Sep 25Dec 25Mar 26Jun 26Sep 26$35.15
$0.00$20.00$40.00$60.00$80.00$100.00Central value $25Entry review $20Jul 25Sep 25Dec 25Mar 26Jun 26Sep 26$35.15
Show the data
DateClose
2025-07-01$73.41
2025-07-31$74.69
2025-08-29$77.37
2025-09-30$69.73
2025-10-29$65.35
2025-11-28$64.63
2025-12-30$61.19
2026-01-30$61.81
2026-03-03$59.39
2026-04-01$44.63
2026-05-01$44.40
2026-06-02$43.73
2026-07-02$44.09
2026-08-03$42.64
2026-09-01$38.12
2026-10-01$35.15
Price reference$32.78
Prior close$35.15
Early reaction-6.74%
52-week range$35.02–$76.97
Quarter endAug 31 2026
Diluted share proxy1,484.2M
Equity value$48.65B
Enterprise value$48.18B
Net financial cash$475M
Forward P/E26.22×
Dividend / EPS midpoint1.31×
UncertaintyHigh
Central value$25
Weighted value$25.30
Entry review$20
Beta1.11
Historical first-session earnings reactions · Percent: next trading-session close / release-day close −1. Current Q1 FY2027 closing reaction remains unavailable; early reference is separate.
−20−1001020Q1 FY2025 · Close-to-close reaction: −6.8Q2 FY2025 · Close-to-close reaction: −0.2Q3 FY2025 · Close-to-close reaction: −5.5Q4 FY2025 · Close-to-close reaction: 15.2Q1 FY2026 · Close-to-close reaction: 6.4Q2 FY2026 · Close-to-close reaction: −10.5Q3 FY2026 · Close-to-close reaction: −15.5Q4 FY2026 · Close-to-close reaction: 4.94.9Q1 FY2025Q2 FY2025Q3 FY2025Q4 FY2025Q1 FY2026Q2 FY2026Q3 FY2026Q4 FY2026
−20−1001020Q1 FY2025 · Close-to-close reaction: −6.8Q2 FY2025 · Close-to-close reaction: −0.2Q3 FY2025 · Close-to-close reaction: −5.5Q4 FY2025 · Close-to-close reaction: 15.2Q1 FY2026 · Close-to-close reaction: 6.4Q2 FY2026 · Close-to-close reaction: −10.5Q3 FY2026 · Close-to-close reaction: −15.5Q4 FY2026 · Close-to-close reaction: 4.94.9Q1FY2025Q2FY2025Q3FY2025Q4FY2025Q1FY2026Q2FY2026Q3FY2026Q4FY2026
Show the data
PeriodClose-to-close reaction
Q1 FY2025−6.77
Q2 FY2025−0.21
Q3 FY2025−5.46
Q4 FY202515.19
Q1 FY20266.41
Q2 FY2026−10.54
Q3 FY2026−15.51
Q4 FY20264.90

The New Quarter and Outlook

The October 1 release covers the first quarter of fiscal 2027, ended August 31, 2026. The income statement places the current quarter first and the August 2025 comparison second. Revenue was $11.213 billion against $11.720 billion a year earlier. Reported sales declined 4%, and currency-neutral sales declined 5%. Gross margin improved to 42.8% from 42.2%, primarily because warehousing and logistics costs were lower. Improvement in the rate did not prevent gross profit dollars from falling, because there was less revenue to apply that rate to.

Demand creation expense increased to $1.252 billion, while operating overhead fell to $2.658 billion. Together they produced $3.910 billion of selling and administrative expense. Marketing investment therefore rose while the administrative cost base contracted. That combination is more constructive than indiscriminate cuts, but the distinction matters: overhead savings support current profit, whereas demand creation still has to earn its return through future customer purchases. Investors should monitor both the margin and the direction of sales rather than treating a lower expense bill as sufficient evidence of a turnaround.

Net income was $712 million and diluted EPS was $0.48. The saved provider consensus showed $0.4365 of EPS and $11.32044 billion of revenue, so the two headline comparisons point in different directions. Those estimates are a dated provider observation rather than company guidance, and their contributor set can change. A modest earnings beat does not settle the broader question raised by the outlook. The more consequential disclosure is that management expects fiscal 2027 revenue to decline at a high-single-digit rate and adjusted EPS of $1.15 to $1.35.

The adjusted EPS outlook excludes approximately $0.15 of fiscal 2027 restructuring expense associated with Pace. Subtracting that estimate gives a simple $1.00 to $1.20 illustrative GAAP bridge, subject to the accuracy and scope of management's estimates. We do not present the adjusted range as unqualified GAAP earnings. The prior fourth quarter also contained a large tariff-recovery benefit; our earlier Nike episode addressed that comparison. This packet instead tests the current sales, cash and restructuring economics without recycling that prior headline.

MeasureQ1 FY27Q1 FY26Context
Revenue$11,213M$11,720M−4% reported;−5% currency-neutral
Gross profit$4,798M$4,943MMargin 42.8% versus 42.2%
Demand creation$1,252M$1,188MMarketing increased
Operating overhead$2,658M$2,828MOverhead declined
SG&A$3,910M$4,016MExpense ratio 34.9%
Operating profit, computed$888M$927MBefore interest and other income
Pretax income$921M$922MOperating/nonoperating mix differs
Net income$712M$727MHigher tax burden
Diluted EPS$0.48$0.49Current share proxy 1,484.2M
Nine-quarter revenue record · USD millions; saved primary statements
05,00010.0K15.0KQ1 FY2025 · Revenue: $11,589.0MQ2 FY2025 · Revenue: $12,354.0MQ3 FY2025 · Revenue: $11,269.0MQ4 FY2025 · Revenue: $11,097.0MQ1 FY2026 · Revenue: $11,720.0MQ2 FY2026 · Revenue: $12,427.0MQ3 FY2026 · Revenue: $11,279.0MQ4 FY2026 · Revenue: $10,972.0MQ1 FY2027 · Revenue: $11,213.0M$11,213.0MQ1 FY2025Q2 FY2025Q3 FY2025Q4 FY2025Q1 FY2026Q2 FY2026Q3 FY2026Q4 FY2026Q1 FY2027
05,00010.0K15.0KQ1 FY2025 · Revenue: $11,589.0MQ2 FY2025 · Revenue: $12,354.0MQ3 FY2025 · Revenue: $11,269.0MQ4 FY2025 · Revenue: $11,097.0MQ1 FY2026 · Revenue: $11,720.0MQ2 FY2026 · Revenue: $12,427.0MQ3 FY2026 · Revenue: $11,279.0MQ4 FY2026 · Revenue: $10,972.0MQ1 FY2027 · Revenue: $11,213.0M$11,213.0MQ1FY2025Q2FY2025Q3FY2025Q4FY2025Q1FY2026Q2FY2026Q3FY2026Q4FY2026Q1FY2027
Show the data
PeriodRevenue
Q1 FY202511,589.00
Q2 FY202512,354.00
Q3 FY202511,269.00
Q4 FY202511,097.00
Q1 FY202611,720.00
Q2 FY202612,427.00
Q3 FY202611,279.00
Q4 FY202610,972.00
Q1 FY202711,213.00
Profit rate improves while profit dollars fall · USD millions; saved primary statements
Gross profitOperating profit
02,0004,0006,000Q1 FY26 · Gross profit: $4,943.0MQ1 FY26 · Operating profit: $927.0MQ1 FY27 · Gross profit: $4,798.0M$4,798.0MQ1 FY27 · Operating profit: $888.0M$888.0MQ1 FY26Q1 FY27
02,0004,0006,000Q1 FY26 · Gross profit: $4,943.0MQ1 FY26 · Operating profit: $927.0MQ1 FY27 · Gross profit: $4,798.0M$4,798.0MQ1 FY27 · Operating profit: $888.0M$888.0MQ1FY26Q1FY27
Show the data
PeriodGross profitOperating profit
Q1 FY264,943.00927.00
Q1 FY274,798.00888.00

Where the Recovery Works — and Where It Does Not

North America remains the clearest support for the recovery thesis. Revenue increased to $5.127 billion from $5.020 billion, and regional EBIT increased to $1.170 billion from $1.134 billion. Those results show that parts of the product and wholesale strategy are working. They do not mean the improvement is geographically complete. Greater China revenue fell to $1.180 billion from $1.512 billion, a 22% reported decline and a 26% currency-neutral decline. Its EBIT fell to $248 million from $377 million. The difference between these regions is more useful than an average that hides both.

EMEA revenue declined to $3.176 billion, with EBIT of $728 million. Asia Pacific and Latin America revenue was $1.463 billion, with EBIT of $324 million. These regional profit figures are segment measures and must be read alongside the global brand and corporate costs retained in the consolidated reconciliation. Adding only the profitable geographic rows would overstate group earning power. The packet displays the full source rows and identifies the reconciliation instead of treating geographic EBIT margins as the margin available to every shareholder.

The channel mix is also uneven. NIKE Brand wholesale sales were $6.804 billion, down 1%, while NIKE Direct sales were $4.142 billion, down 8% reported and 9% on a currency-neutral basis. Brand Digital sales declined 13% and owned-store sales declined 5%. Wholesale stabilization helps, but the direct channel carries an important consumer signal. We would be more comfortable underwriting an earnings recovery when digital and store trends improve together, rather than relying on partner inventory and distribution alone.

Product categories tell a similar story. NIKE Brand footwear revenue was $6.951 billion, apparel was $3.384 billion and equipment was $611 million. Apparel improved while footwear and equipment declined. Converse revenue fell to $263 million, down 28%. Management is repositioning Sportswear, Jordan and Greater China while extending the Sport Offense. Those are material operating choices, not separate pools of value that can simply be added to the stock price. The next test is whether better product execution changes the sales trajectory without sacrificing the gross-margin improvement already achieved.

Regional revenue · USD millions; current issuer release
North AmericaNorth America: $5,127.0M$5,127.0MEMEAEMEA: $3,176.0M$3,176.0MGreater ChinaGreater China: $1,180.0M$1,180.0MAPLAAPLA: $1,463.0M$1,463.0M
North AmericaNorth America: $5,127.0M$5,127.0MEMEAEMEA: $3,176.0M$3,176.0MGreater ChinaGreater China: $1,180.0M$1,180.0MAPLAAPLA: $1,463.0M$1,463.0M
Show the data
MeasureValue
North America5,127.00
EMEA3,176.00
Greater China1,180.00
APLA1,463.00
Regional EBIT comparisons · Segment EBIT; excludes global brand and corporate reconciliation costs.
Q1 FY26Q1 FY27
05001,0001,500North America · Q1 FY26: $1,134.0MNorth America · Q1 FY27: $1,170.0MEMEA · Q1 FY26: $735.0MEMEA · Q1 FY27: $728.0MGreater China · Q1 FY26: $377.0MGreater China · Q1 FY27: $248.0MAPLA · Q1 FY26: $350.0M$350.0MAPLA · Q1 FY27: $324.0M$324.0MNorth AmericaEMEAGreater ChinaAPLA
05001,0001,500North America · Q1 FY26: $1,134.0MNorth America · Q1 FY27: $1,170.0MEMEA · Q1 FY26: $735.0MEMEA · Q1 FY27: $728.0MGreater China · Q1 FY26: $377.0MGreater China · Q1 FY27: $248.0MAPLA · Q1 FY26: $350.0M$350.0MAPLA · Q1 FY27: $324.0M$324.0MNorthAmericaEMEAGreaterChinaAPLA
Show the data
PeriodQ1 FY26Q1 FY27
North America1,134.001,170.00
EMEA735.00728.00
Greater China377.00248.00
APLA350.00324.00
Wholesale and direct channels · USD millions; saved primary statements
Q1 FY26Q1 FY27
02,0004,0006,0008,000Wholesale · Q1 FY26: $6,839.0MWholesale · Q1 FY27: $6,804.0MNIKE Direct · Q1 FY26: $4,514.0M$4,514.0MNIKE Direct · Q1 FY27: $4,142.0M$4,142.0MWholesaleNIKE Direct
02,0004,0006,0008,000Wholesale · Q1 FY26: $6,839.0MWholesale · Q1 FY27: $6,804.0MNIKE Direct · Q1 FY26: $4,514.0M$4,514.0MNIKE Direct · Q1 FY27: $4,142.0M$4,142.0MWholesaleNIKEDirect
Show the data
PeriodQ1 FY26Q1 FY27
Wholesale6,839.006,804.00
NIKE Direct4,514.004,142.00
Operating signalCurrentYear-over-year context
Digital sales−13%NIKE Brand Digital
Owned-store sales−5%NIKE-owned stores
Converse revenue$263M−28% reported
Footwear revenue$6,951MPrior $7,410M
Apparel revenue$3,384MPrior $3,313M
Equipment revenue$611MPrior $630M

From Gross Profit to Shareholders

The quarter's earnings bridge starts with $4.798 billion of gross profit and subtracts $3.910 billion of selling and administrative expense. That leaves $888 million of operating profit by arithmetic. Net interest income contributed $14 million and other net income contributed $19 million, bringing pretax income to $921 million. Tax expense of $209 million then leaves the reported $712 million of net income. The bridge separates operating performance from financing and other items, so a reader can see where the reported result was earned.

A year earlier the comparable operating-profit calculation was $927 million. The reduction in overhead softened the impact of lower gross profit, but it did not produce growth in operating dollars. Other income also compares favorably with the prior-year other expense. Pretax income was therefore almost unchanged even as operating profit declined. The higher effective tax rate then pushed net income lower. This is a reason to examine the full bridge rather than infer that a stable bottom line means underlying demand has stopped deteriorating.

The current effective tax rate was 22.7%, compared with 21.1% a year earlier, partly because of foreign tax audit settlements. Management expects a mid-twenties rate for fiscal 2027, subject to earnings mix and discrete items. Our forward EPS route uses the company's already-taxed adjusted guidance and therefore does not subtract tax again. The enterprise route uses operating earnings and an enterprise multiple, with net financial cash added once. Keeping those routes separate prevents double counting a balance-sheet benefit or charging the same financing cost twice.

Pace introduces another distinction between accounting profit and cash. Management expects approximately $1.0 billion of additional pretax charges through fiscal 2031, including about $0.3 billion in fiscal 2027, beyond roughly $0.3 billion recognized in fiscal 2026 under the earlier cost realignment plan. The program is expected to generate approximately $2.5 billion of cumulative savings through fiscal 2031, before these charges and any reinvestment. Cumulative savings are not an annual profit run rate. We do not capitalize the entire $2.5 billion as if it recurred every year or assume all savings become distributable cash.

Quarter income bridge · Operating profit is computed before other income; issuer EBIT includes other income.
02,0004,0006,000Gross profit: $4,798M$4,798MGrossprofitSG&A: −$3,910M−$3,910MSG&AOperating: $888M$888MOperatingNet interest: $14M$14MNetinterestOther income: $19M$19MOtherincomePretax: $921M$921MPretaxTax: −$209M−$209MTaxNet income: $712M$712MNet income
02,0004,0006,000Gross profit: $4,798M$4,798MGross profitSG&A: −$3,910M−$3,910MSG&AOperating: $888M$888MOperatingNet interest: $14M$14MNet interestOther income: $19M$19MOther incomePretax: $921M$921MPretaxTax: −$209M−$209MTaxNet income: $712M$712MNet income
Show the data
Step$M
Gross profit4798
SG&A−3910
Operating profit888
Net interest income14
Other income19
Pretax921
Tax−209
Net income712
Pace estimates are cumulative and differently scoped · Company estimates; savings before charges / reinvestment. Not annual recurring amounts.
Savings through FY31Savings through FY31: $2,500.0M$2,500.0MAdditional charges through FY31Additional charges through FY31: $1,000.0M$1,000.0MExpected FY27 chargesExpected FY27 charges: $300.0M$300.0M
Savings through FY31Savings through FY31: $2,500.0M$2,500.0MAdditional charges through FY31Additional charges through FY31: $1,000.0M$1,000.0MExpected FY27 chargesExpected FY27 charges: $300.0M$300.0M
Show the data
MeasureValue
Savings through FY312,500.00
Additional charges through FY311,000.00
Expected FY27 charges300.00

Nine Checks on Earnings Quality

Our earnings-quality scorecard separates nine recurring questions: stock compensation, the GAAP-to-adjusted gap, below-the-line support, minority leakage, cash conversion, receivables, inventory, tax and the guidance record. The purpose is to identify what requires verification, not to compress unlike accounting issues into a reassuring average. NIKE's release supplies the current income statement and balance sheet, but it does not yet supply a fiscal first-quarter cash-flow statement. That missing statement remains a dated gap. We do not infer operating cash generation by subtracting two cash balances.

Receivables were $5.242 billion at August 31, compared with $4.962 billion a year earlier. Sales declined over the corresponding quarter. A simple ending-balance receivable-days proxy therefore rises. It is a warning to inspect collections and channel mix, not proof of improper recognition. The proxy uses ninety days and the quarter's revenue rather than a daily average of receivables. Seasonal shipment patterns and wholesale terms can affect it, so we show the definition and compare consistent periods.

Inventory was $7.846 billion, below the prior-year $8.114 billion, but cost of sales also declined. The ending-balance inventory-days proxy can therefore worsen despite a lower inventory balance. Management attributes the balance change primarily to product mix. Inventory quality depends on the mix, age and eventual selling price, not simply the total dollars. An inventory reduction achieved through healthy sell-through is more valuable than the same reduction achieved through heavy discounting that gives back the gross-margin recovery.

The annual cash record provides a useful discipline while the new quarter's statement is pending. Fiscal 2026 operating cash flow was $2.868 billion and capital spending was $684 million, leaving $2.184 billion of free cash flow by subtraction. Stock compensation was $715 million. A conservative owner-cash proxy deducts that compensation from free cash flow to recognize its economic cost, while acknowledging that the accounting expense and ultimate dilution are not identical. We use that proxy as one valuation input and disclose it explicitly; it is not an alternative cash-flow statement published by NIKE. The annual report separately records $385 million of total severance across its stated scope, including $142 million paid and $243 million remaining liability. The release's approximate prior-plan amount is not substituted for that broader annual total.

▲ WatchStock compensation
$715M FY26
Economic cost deducted in owner-cash proxy
▲ WatchGAAP / adjusted
$0.15 FY27
Expected restructuring exclusion from adjusted EPS
▲ WatchBelow-the-line
$33M net income
Interest plus other income before tax
• n/aMinority leakage
No separate NCI line
Consolidated release does not present minority deductions
▲ WatchCash conversion
Q1 pending
No current cash-flow statement; FY26 FCF $2.184B
▲ WatchReceivable days
42.1
Ending balance / quarterly sales ×90
▲ WatchInventory days
110.1
Ending balance / quarterly cost ×90
▲ WatchTax
22.7%
FY27 outlookmid-20s
▲ WatchGuidance record
Reset underway
New annual guide must be tested with later results
Ending-balance working-capital proxies · Computed ending-balance proxies;90-day quarter, not company reported DSO.
Q1 FY26Q1 FY27
050100150Receivable days · Q1 FY26: 38.1Receivable days · Q1 FY27: 42.1Inventory days · Q1 FY26: 107.8107.8Inventory days · Q1 FY27: 110.1110.1Receivable daysInventory days
050100150Receivable days · Q1 FY26: 38.1Receivable days · Q1 FY27: 42.1Inventory days · Q1 FY26: 107.8107.8Inventory days · Q1 FY27: 110.1110.1ReceivabledaysInventorydays
Show the data
PeriodQ1 FY26Q1 FY27
Receivable days38.1042.07
Inventory days107.76110.08
Three fiscal years of cash generation · USD millions; saved primary statements
Operating cashCapital expenditureFree cash flow
02,5005,0007,50010.0KFY2024 · Operating cash: $7,429.0MFY2024 · Capital expenditure: $812.0MFY2024 · Free cash flow: $6,617.0MFY2025 · Operating cash: $3,698.0MFY2025 · Capital expenditure: $430.0MFY2025 · Free cash flow: $3,268.0MFY2026 · Operating cash: $2,868.0M$2,868.0MFY2026 · Capital expenditure: $684.0M$684.0MFY2026 · Free cash flow: $2,184.0M$2,184.0MFY2024FY2025FY2026
02,5005,0007,50010.0KFY2024 · Operating cash: $7,429.0MFY2024 · Capital expenditure: $812.0MFY2024 · Free cash flow: $6,617.0MFY2025 · Operating cash: $3,698.0MFY2025 · Capital expenditure: $430.0MFY2025 · Free cash flow: $3,268.0MFY2026 · Operating cash: $2,868.0M$2,868.0MFY2026 · Capital expenditure: $684.0M$684.0MFY2026 · Free cash flow: $2,184.0M$2,184.0MFY2024FY2025FY2026
Show the data
PeriodOperating cashCapital expenditureFree cash flow
FY20247,429.00812.006,617.00
FY20253,698.00430.003,268.00
FY20262,868.00684.002,184.00

The Cash Bill Behind the Reset

The August balance sheet contains $6.903 billion of cash and equivalents and $1.465 billion of short-term investments. Together that is $8.368 billion of liquid financial assets. Against them stand $2.000 billion of current debt and $5.893 billion of long-term debt. The resulting net financial cash is only $475 million. Gross cash remains an important liquidity resource, but adding all of it to an equity valuation while ignoring the borrowings would materially overstate the cushion.

Operating lease obligations are shown separately. We exclude them from the simple net financial cash measure and use operating earnings consistently in the enterprise comparison. This is a disclosed convention, not a claim that stores or other leased facilities have no economic cost. A more elaborate lease-adjusted valuation would need to adjust both enterprise value and its earnings denominator together. We do not add lease debt to one side while leaving the other side on an incompatible basis.

Capital allocation is under pressure. Fiscal 2026 dividends of $2.407 billion exceeded the computed $2.184 billion of free cash flow. Buybacks were much smaller than in prior years, and the company had paused repurchases during fiscal 2026. The $18 billion authorization was extended without a fixed expiration date and without increasing its total capacity. Authorization is permission, not a commitment or an extra asset. A stronger buyback program would need support from cash generation and liquidity after dividends, investment and restructuring requirements.

The current quarter returned about $610 million through dividends. The declared quarterly dividend was $0.410 a share. Annualizing that payment gives $1.64, above the midpoint of fiscal 2027 adjusted EPS guidance. This comparison does not predict a dividend reduction: boards can draw on cash, earnings and cash flow differ, and the full year's payment has not been declared. It does show why investors should demand a credible funding bridge. A high dividend yield is less reassuring when the business also needs cash to finance its own repair.

Gross liquidity versus financial debt · USD millions; current issuer release
CashCash: $6,903.0M$6,903.0MShort investmentsShort investments: $1,465.0M$1,465.0MCurrent debtCurrent debt: $2,000.0M$2,000.0MLong debtLong debt: $5,893.0M$5,893.0MNet cashNet cash: $475.0M$475.0M
CashCash: $6,903.0M$6,903.0MShort investmentsShort investments: $1,465.0M$1,465.0MCurrent debtCurrent debt: $2,000.0M$2,000.0MLong debtLong debt: $5,893.0M$5,893.0MNet cashNet cash: $475.0M$475.0M
Show the data
MeasureValue
Cash6,903.00
Short investments1,465.00
Current debt2,000.00
Long debt5,893.00
Net cash475.00
Cash distributions and compensation · USD millions; saved primary statements
DividendsRepurchasesStock compensation
02,0004,0006,000FY2024 · Dividends: $2,169.0MFY2024 · Repurchases: $4,250.0MFY2024 · Stock compensation: $804.0MFY2025 · Dividends: $2,300.0MFY2025 · Repurchases: $2,985.0MFY2025 · Stock compensation: $709.0MFY2026 · Dividends: $2,407.0M$2,407.0MFY2026 · Repurchases: $146.0M$146.0MFY2026 · Stock compensation: $715.0M$715.0MFY2024FY2025FY2026
02,0004,0006,000FY2024 · Dividends: $2,169.0MFY2024 · Repurchases: $4,250.0MFY2024 · Stock compensation: $804.0MFY2025 · Dividends: $2,300.0MFY2025 · Repurchases: $2,985.0MFY2025 · Stock compensation: $709.0MFY2026 · Dividends: $2,407.0M$2,407.0MFY2026 · Repurchases: $146.0M$146.0MFY2026 · Stock compensation: $715.0M$715.0MFY2024FY2025FY2026
Show the data
PeriodDividendsRepurchasesStock compensation
FY20242,169.004,250.00804.00
FY20252,300.002,985.00709.00
FY20262,407.00146.00715.00
Balance-sheet itemAug 31 2026 $MDefinition / caution
Cash + short investments8,368Liquid financial assets
Funded debt7,893Current 2,000 plus long-term 5,893
Net financial cash475Excludes leases
Operating lease liabilities3,179Current 473 plus long-term 2,706
Receivables5,242Ending balance
Inventory7,846Product mix and sellthrough matter
Total assets37,794Not all liquid
Equity15,220Book value is not fair value

Three Routes and a Reverse Test

Our central value is $25 a share, within a deliberately broad $16 to $40 scenario range. Three routes support the judgment. The first applies a 22-times multiple to the $1.25 midpoint of fiscal 2027 adjusted EPS guidance, producing $27.50. Both the multiple and our willingness to look through restructuring are analyst assumptions. The calculation already grants the brand a meaningful recovery premium despite the expected revenue decline. Applying an even higher multiple requires stronger evidence that today's depressed earnings will recover rather than simply remain depressed.

The second route models $43.5 billion of future annual sales and a 5.5% operating margin, producing $2.3925 billion of operating profit. These are our normalized assumptions, not management guidance. Applying a 15-times enterprise multiple, adding $475 million of net financial cash and dividing by the 1,484.2 million diluted-share proxy produces approximately $24.50 a share. This route requires stabilization and operating execution. A sensitivity grid changes the margin and multiple so the reader can see how much of the conclusion rests on those choices.

The third route starts with $1.5 billion of annual owner cash, grows it 15% for the subsequent four years, discounts the five annual payments at 10%, and uses 2.5% perpetual growth thereafter. The result is about $20 a share. Owner cash means operating cash less capital spending and an economic stock-compensation allowance. Because this is a levered equity cash-flow route, we do not subtract borrowing or add cash a second time. The model embeds substantial improvement, yet produces the lowest of the three values. That is the principal reason we resist using an optimistic earnings multiple as the entire thesis.

At the saved reference, the market pays more than our base assumptions justify. The reverse test asks how much initial owner cash would be needed to support that price with the same growth, discount rate and terminal growth. It also asks what multiple investors are paying on the company's guidance midpoint. Those are transparent hurdle rates, not precise forecasts. Our bear, base and bull weights are 30%, 50% and 20%, respectively; their $16, $25 and $40 values produce $25.30 of probability-weighted value. High uncertainty leads us to seek a 20% margin below central value for a potential entry review, or $20, provided the operating thesis still holds.

1

Forward earnings

$1.25 adjusted EPS midpoint ×22 = $27.50. Analyst multiple; no added cash.

2

Normalized operating profit

$43,500M sales ×5.5% ×15 +$475M net cash, divided by 1,484.2M shares = $24.50. Analyst normalized assumptions.

3

Owner cash

$1,500M initial equity cash, 15% growth for 4 steps, 10% discount rate and 2.5% terminal growth = $20.03. No second debt or cash adjustment.

Operating margin and enterprise multiple sensitivity · USD per share; normalized sales $43.5B, net cash $475M, shares 1,484.2M.
EV / operating profit12×15×18×21×4.0%$14.39$14.39$17.91$17.91$21.42$21.42$24.94$24.945.0%$17.91$17.91$22.30$22.30$26.70$26.70$31.09$31.095.5%$19.66$19.66$24.50$24.50$29.34$29.34$34.17$34.176.0%$21.42$21.42$26.70$26.70$31.97$31.97$37.25$37.257.0%$24.94$24.94$31.09$31.09$37.25$37.25$43.40$43.40Margin
EV / operating profit12×15×18×21×4.0%$14.39$14.39$17.91$17.91$21.42$21.42$24.94$24.945.0%$17.91$17.91$22.30$22.30$26.70$26.70$31.09$31.095.5%$19.66$19.66$24.50$24.50$29.34$29.34$34.17$34.176.0%$21.42$21.42$26.70$26.70$31.97$31.97$37.25$37.257.0%$24.94$24.94$31.09$31.09$37.25$37.25$43.40$43.40Margin
Show the data
Margin / multiple12×15×18×21×
4.0%$14.39$17.91$21.42$24.94
5.0%$17.91$22.30$26.70$31.09
5.5%$19.66$24.50$29.34$34.17
6.0%$21.42$26.70$31.97$37.25
7.0%$24.94$31.09$37.25$43.40
Reverse testComputed requirementInterpretation
Forward P/E26.22×Price / company EPS midpoint
EPS at22×$1.49Above $1.25 guide midpoint
Initial owner cash$2,455MSame 15% growth / 10% discount / 2.5% terminal
EV / normalized operating profit20.14×Versus our 15× route
Central value return−23.7%Value/price−1; not forecast return

Fresh Results, Older Street Targets

The saved analyst target consensus is $46.45, with a $44 median and a $30 to $75 range. The ratings snapshot contains 33 buy or strong-buy observations, 31 holds and 7 sells. These are provider aggregates with their own update schedules. They should not be mistaken for a set of fresh opinions incorporating every line of the October release. Our $25 central value is more cautious because the owner-cash route and near-term outlook leave less room for a smooth recovery than a simple brand multiple suggests.

The dated target-news record illustrates the issue. RBC Capital lowered its target to $40 on September 29. HSBC moved to $40 and Deutsche Bank to $37 on September 28, while Piper Sandler moved to $38 that day. These were already cautious revisions, but they preceded the current print. A target can be recent on the calendar and still be stale with respect to the information being analyzed. The table therefore retains firm, publication date and target rather than placing all observations under an undated Wall Street label.

The provider's fiscal 2027 EPS consensus is about $1.674, compared with management's newly stated adjusted range of $1.15 to $1.35. Revenue consensus is approximately $45.341 billion, whereas management describes a high-single-digit decline from fiscal 2026 revenue of $46.398 billion. Differences in estimate timing and adjusted definitions mean these are not perfectly interchangeable forecasts. Nevertheless, the gap is economically meaningful and makes subsequent estimate revisions a useful catalyst to watch. We do not manufacture a fully revised consensus immediately after publication.

The strongest challenge to our caution is that analysts may be valuing a later earnings base. If brand demand and direct sales stabilize sooner than our cash model assumes, a future EPS level near $2 could justify a much higher price at a twenty-times multiple. Our bull scenario makes that possibility explicit. The disagreement is about the probability, timing and cash cost of getting there. A favorable brand history is evidence of opportunity; it is not proof that the current reset will reach the optimistic outcome on schedule.

Ratings on record · Saved provider aggregate;71ratings, mixed update dates.
Buy / strong buyBuy / strong buy: 3333HoldHold: 3131SellSell: 77
Buy / strong buyBuy / strong buy: 3333HoldHold: 3131SellSell: 77
Show the data
MeasureValue
Buy / strong buy33.00
Hold31.00
Sell7.00
FirmDateTarget
RBC Capital2026-09-29$40.00
HSBC2026-09-28$40.00
Deutsche Bank2026-09-28$37.00
Piper Sandler2026-09-28$38.00
Oppenheimer2026-09-23$52.00
Barclays2026-09-23$48.00
Stifel Nicolaus2026-09-21$40.00
UBS2026-09-17$42.00
All listed target-news items precede October 1release.
Year ending May31Revenue $MEPSEPS analyst count
202948,039.642.2717
202846,816.602.0728
202745,341.121.6727
Provider estimates may not yet reflect the new company guide.

Grade Delivery, Not Program Names

Management deserves credit for protecting marketing investment while cutting overhead and improving logistics economics. The quarter shows that those choices can support margin even when revenue contracts. The scorecard also records where execution is incomplete: direct sales continue to decline, Greater China is weak and Converse remains under pressure. We separate statements of strategic intent from measured outcomes. Describing a program as a transformation is not itself evidence that the program has created value.

Pace combines supply-chain modernization, a new campus in India, a realignment into three geographies and additional organizational streamlining. Its multi-year design creates both opportunity and execution risk. Savings may arrive later than cash charges, local labor requirements can affect timing, and reinvestment can absorb some of the gross benefits. The appropriate scorecard tracks realized recurring savings, cumulative cash costs and operating performance together. Counting savings while ignoring disrupted sales or necessary reinvestment would produce an incomplete assessment.

The leadership and governance record is also relevant. The annual report identifies PricewaterhouseCoopers as auditor, and shareholders ratified its appointment for fiscal 2027 at the completed September meeting. NIKE has Class A and Class B shares with different director-election rights; Class B is the listed security. The controlling influence associated with Class A ownership matters when assessing accountability, even though both classes participate economically in the business. These are disclosed structural considerations, not evidence of an unresolved contested proxy.

Our questions are concrete. How much of the expected savings is genuinely incremental after reinvestment? How will management distinguish healthier direct demand from clearance activity? What proportion of the inventory improvement represents units rather than mix or pricing? When will annual free cash flow again cover dividends with room for restructuring? Which metrics would cause management to change the pace or scope of the program? A useful answer should connect a number, a date and an accountable operating decision. The next packet will grade those answers against the signposts established here.

DecisionEvidenceAssessment
Cost disciplineOverhead down 6%, demand creation up 5%Constructive mix, sales still weak
Channel repairDirect down 8%, wholesale down1%Incomplete
Pace economics$2.5Bcumulative savings before$1Bcharges / reinvestmentConditional, multi-year
Cash allocationFY26 dividends exceed $2.184B FCFFunding test
GovernanceCompleted annual vote; PwC ratifiedNo current contested proxy established

The Cases on Both Sides

The highest operating risk is that the demand problem outlasts the cost reset. Footwear and direct sales are still declining, and an expense program cannot indefinitely substitute for products that customers want to buy at attractive prices. We rate this risk high in likelihood and high in impact relative to the valuation. The next is Greater China: the regional decline is severe enough that modest progress elsewhere can be overwhelmed. Currency-neutral disclosure helps distinguish translation from the underlying commercial challenge.

The next risk is cash timing. Restructuring charges, capital investment, dividends and working-capital needs can overlap before savings mature. The balance sheet provides liquidity, but the net financial cushion is considerably smaller than gross cash suggests. Supplier and geographic concentration also matter. The annual report discloses that several large contract manufacturers account for substantial footwear production, and trade policy can affect costs and cash recovery. These risks should influence the required margin of safety rather than be treated as boilerplate after selecting a price target.

The bull case is that performance products regain momentum, wholesale partners support a healthier marketplace and direct sales stabilize without another margin sacrifice. North America's growth and the gross-margin improvement support that argument. Successful execution could restore investor confidence before reported annual cash flow fully recovers, and the stock could rise well before our preferred entry level is reached. A cautious valuation can therefore be wrong through excessive conservatism as well as through bad arithmetic.

The bear case is that lower sales, continued China weakness and a persistent dividend funding gap force a longer reset. Our $16 scenario is not a liquidation estimate or a guaranteed floor; it represents weaker sustainable earnings and a lower multiple. The bull value is not a ceiling either. The broad distribution is why conviction is moderate and uncertainty high. The practical decision is to avoid paying for an uncomplicated recovery until the evidence or the price changes, while retaining clear conditions that would make us reconsider.

RiskLikelihoodImpactWatch
Demand recovery delayedHighHighDirect / footwear sales
Greater China weaknessHighHighCurrency-neutral regional trend
Restructuring cash timingMediumHighCash paid vs realized savings
Inventory qualityMediumHighMix/clearance/grossmargin
Concentration / tradeMediumHighManufacturing locations and tariffs
Recovery faster than modelMediumHighRisk to our cautious call

Dated Tests for the Next Update

The next scheduled analytical checkpoint is the fiscal second quarter ending November 30, 2026. The release date is not assumed in this packet. We will compare direct-sales growth, Greater China revenue, gross margin and the EPS outlook against today's definitions. A subsequent first-quarter 10-Q, when filed, should also supply the cash-flow information absent from the earnings exhibit. That statement is an important evidence update even if it arrives without a dramatic share-price move.

Estimate revisions are another near-term catalyst. The saved Street forecasts do not yet match the company's newly released outlook, so changes in targets or consensus may reflect information already present in this packet rather than genuinely new operating news. We will distinguish a change in analyst opinion from a change in company fundamentals. The most useful positive revision would be supported by improved sales, margins or cash conversion; the least useful would simply apply a larger multiple to the same uncertain earnings base.

The multi-year Pace program creates a longer calendar. Fiscal 2027 charges are expected to be about $0.3 billion, with additional charges and savings extending through fiscal 2031. We will ask whether the company reports milestones in a way that allows cumulative commitments to be compared with cumulative delivery. A program that continually resets its baseline is difficult to grade. Until clearer milestones exist, the $2.5 billion savings estimate belongs in a conditional scenario rather than a mechanical addition to current earnings.

Price is also a catalyst, but only alongside the business. A move toward $20 would prompt an entry review under our present $25 central value and high-uncertainty margin requirement. It would not automatically create a BUY if guidance, liquidity or competitive position deteriorated at the same time. Conversely, better direct demand, less severe China declines and stronger cash coverage could raise fair value before the stock reaches that level. The signposts deliberately allow both routes to a different conclusion.

CheckpointDate / periodRequired evidence
First-quarter10-QWhen filed; date unconfirmedQuarter cash flow and footnotes
Next operatingquarterEnds November 30, 2026Direct/China/margin/guide
FY27 Pace costFiscal yearendingMay31,2027About $300M expectedcharges
Pace cumulativeprogramThrough FY2031Savings before costs / reinvestment
Valuation entryreviewEach material filingAround $20 only if thesis intact

Financial Record and Source Methods

The dataset retains nine quarterly releases from Q1 fiscal 2025 through Q1 fiscal 2027, plus annual financial statements and three fiscal years of cash flows. Source URLs, saved files and exact table headings accompany the records. Annual and quarterly values are kept distinct. A fourth-quarter income statement can be obtained directly from its earnings release; a cash-flow figure derived from annual less nine-month statements is labeled as computed. Missing current-quarter cash-flow information remains missing rather than being filled with a provider estimate.

All amounts are in U.S. dollars unless a table states otherwise. Financial-statement tables use millions, while EPS, dividends and valuation outputs use dollars per share. Currency-neutral growth is the company's non-GAAP translation measure; it is not an alternative dollar revenue amount. Share-based compensation, restructuring charges and the tariff recovery are identified separately when disclosed. We do not invent a universal adjusted operating-profit series for periods in which the issuer did not publish that measure.

Derived values are calculated from the saved dataset: margins, growth, operating profit, net financial cash, working-capital days, free cash flow, owner-cash proxies, valuation routes and scenario weighting. Ending-balance day measures use ninety days and are comparisons rather than precise collection or inventory-turn schedules. The diluted weighted-average share count is a valuation proxy with a clearly stated limitation. Assumptions such as multiples, discount rates, growth rates, normalized revenue and scenario probabilities are ours and can be varied in the sensitivity analysis.

This is a new-period analysis rather than a rewrite of the prior Q4 fiscal 2026 videos. Their titles and identities are retained in the source review, and the current thesis focuses on sales recovery, restructuring economics and cash funding. No prior structured packet signposts for this exact comparison were established in the available packet record, so we do not fabricate a graded track record. Future updates should preserve today's assumptions and report which tests improved, which failed and why the valuation changed.

QuarterRevenue $MOperating $MNet income $MDiluted EPS
Q1 FY202511,589.001,209.001,051.000.70
Q2 FY202512,354.001,384.001,163.000.78
Q3 FY202511,269.00788.00794.000.54
Q4 FY202511,097.00321.00211.000.14
Q1 FY202611,720.00927.00727.000.49
Q2 FY202612,427.001,006.00792.000.53
Q3 FY202611,279.00553.00520.000.35
Q4 FY202610,972.001,311.001,069.000.72
Q1 FY202711,213.00888.00712.000.48
Fiscal yearOCF $MCapex $MFCF $MSBC $MDividends $M
FY20247,4298126,6178042,169
FY20253,6984303,2687092,300
FY20262,8686842,1847152,407
StructureVerified context
ListingNYSE: NKE Class B common stock; no ADS
VotingClass A and Class B have different director-election rights
AuditorPricewaterhouseCoopers; since 1974
EmployeesApproximately 73,000 at May 31, 2026
Customer concentrationNo customer 10%+ of FY26 revenue
ManufacturingFour footwear manufacturers: about 60% of FY26 production
Repurchases$18B authorization extended without fixed expiration; paused FY26